Pravastatin Teva

/ Teva

Please refer to the manufacturer for further details.

In patients at increased risk of atherosclerotic vascular disease due to hypercholesterolemia. In addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone had been inadequate. Primary prevention of coronary events: In hypercholesterolemic patients without clinically evident coronary heart disease to reduce risks of MI, revascularization, and deaths due to cardiovascular causes with no incr. in deaths from non-cardiovascular causes. Secondary prevention of cardiovascular events: Atherosclerosis in hypercholesterolemic patients with clinically evident coronary artery disease, including prior MI to slow the progression of coronary ather-osclerosis and reduce the risk of acute coronary events. In myocardial infarction: In patients with previous MI and normal cholesterol levels to reduce the risk of recurring MI, risk of undergoing myocardial revasculization procedure and reduce the risk of stroke or transient ischemic attacks. In hypercholesterolemia and mixed dyslipidemia: As adjunctive to diet to reduce elevated total cholesterol, LDL-cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia.

Known hypersensitivity to any ingredient, pregnancy, lactation. Active liver disease or unexplained, persistent elevation in liver function tests.
Please refer to the manufacturer for further details.

Please refer to the manufacturer for further details.

Please refer to the manufacturer for further details.

N/A.